By Linda A. Johnson, Associated Press – Sept 25, 2015
Sticker-shocked patients increasingly wonder why prices for prescription drugs continue to rise in the US.
The issue heated up this week with the news that Turing Pharmaceuticals raised the price of Daraprim, the only approved treatment for a rare, life-threatening parasitic infection, by more than 5,000% to $750 a pill.
Medical groups blasted the increase, and Democratic presidential candidate Hillary Clinton called it “price gouging.” Turing’s CEO, former hedge fund manager Martin Shkreli, later said he’d make “a serious price adjustment.”
